Vaxart, Inc. (NASDAQ:VXRT) Q4 2025 Earnings Call Transcript March 12, 2026 Vaxart, Inc. beats earnings expectations. Reported ...
Vaxart (OTCMKTS:VXRT) used its fourth-quarter business update and year-end 2025 financial results conference call to ...
Vaxart Inc. (VXRT) reported a remarkable increase in revenue for the fourth quarter of 2025, driven largely by government contracts and a significant partnership with Dynavax. The company’s revenue ...
March S&P 500 E-Mini futures (ESH26) are down -0.62%, and March Nasdaq 100 E-Mini futures (NQH26) are down -0.61% this morning as the escalating Middle East conflict pushes oil prices higher and ...
A stock trading under $2, often referred to as a penny stock, can often look like a bargain, especially when it starts moving quickly. That low price is what draws many investors in, since even small ...
3mon
Vaxart Inc.
About Vaxart Inc. Vaxart, Inc. is a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results